Financials Albemarle Corporation

Equities

ALB

US0126531013

Specialty Chemicals

Market Closed - Nyse 04:00:02 2024-12-06 pm EST 5-day change 1st Jan Change
104.96 USD +3.82% Intraday chart for Albemarle Corporation -2.80% -27.35%

Projected Income Statement: Albemarle Corporation

Forecast Balance Sheet: Albemarle Corporation

balance-sheet-analysis-chart ALBEMARLE-CORPORATION
Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 2,437 2,825 1,955 1,718 3,277 2,562 3,747 3,952
Change - 15.92% -30.8% -12.12% 90.75% -21.82% 46.25% 5.47%
Announcement Date 2/19/20 2/17/21 2/16/22 2/15/23 2/14/24 - - -
1USD in Million
Estimates

Cash Flow Forecast: Albemarle Corporation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
CAPEX 1 851.8 850.5 953.7 1,262 2,149 1,723 983.5 997.6
Change - -0.15% 12.13% 32.29% 70.36% -19.84% -42.92% 1.43%
Free Cash Flow (FCF) 1 -132.4 -51.56 -609.4 646.2 -824 -1,107 -117.4 195.6
Change - -61.06% 1,081.87% -206.04% -227.51% 34.31% -89.39% -266.57%
Announcement Date 2/19/20 2/17/21 2/16/22 2/15/23 2/14/24 - - -
1USD in Million
Estimates

Forecast Financial Ratios: Albemarle Corporation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026

Profitability

        
EBITDA Margin (%) 28.88% 26.17% 26.17% 47.48% 35.05% 19.46% 22.1% 25.1%
EBIT Margin (%) 22.94% 18.75% 18.54% 43.37% 30.57% 8.43% 8.57% 14.26%
EBT Margin (%) 15.68% 11.94% 4.02% 33.24% 2.57% -39.92% 9.12% 28.58%
Net margin (%) 14.86% 12.01% 3.72% 36.75% 16.36% -25.23% 13.89% 38.2%
FCF margin (%) -3.69% -1.65% -18.31% 8.83% -8.57% -20.13% -2.01% 2.87%
FCF / Net Income (%) -24.83% -13.72% -492.76% 24.02% -52.37% 79.81% -14.44% 7.52%

Profitability

        
ROA 7.37% 3.7% 4.39% 19.57% 15.54% -4.02% 3.87% 6.58%
ROE 17.09% 9.16% 8.31% 19.01% 30.12% -1.73% 4.92% 4.06%

Financial Health

        
Leverage (Debt/EBITDA) 2.35x 3.45x 2.24x 0.49x 0.97x 2.39x 2.9x 2.31x
Debt / Free cash flow -18.4x -54.79x -3.21x 2.66x -3.98x -2.31x -31.92x 20.21x

Capital Intensity

        
CAPEX / Current Assets (%) 23.73% 27.18% 28.66% 17.24% 22.35% 31.35% 16.81% 14.66%
CAPEX / EBITDA (%) 82.16% 103.88% 109.49% 36.3% 63.77% 161.04% 76.06% 58.4%
CAPEX / FCF (%) -643.24% -1,649.39% -156.49% 195.24% -260.85% -155.69% -837.72% 510.11%

Items per share

        
Cash flow per share 1 6.766 7.48 2.972 16.2 11.25 10.71 8.55 13.55
Change - 10.55% -60.27% 445.01% -30.52% -4.85% -20.15% 58.46%
Dividend per Share 1 1.47 1.54 1.56 1.58 1.6 1.617 1.655 1.678
Change - 4.76% 1.3% 1.28% 1.27% 1.09% 2.31% 1.39%
Book Value Per Share 1 37.08 39.95 48.07 67.77 80.17 81.99 77.61 78.94
Change - 7.73% 20.34% 40.97% 18.3% 2.26% -5.35% 1.72%
EPS 1 5.02 3.52 1.06 22.84 13.36 -12.1 7.242 15.39
Change - -29.88% -69.89% 2,054.72% -41.51% -190.58% -159.84% 112.48%
Nbr of stocks (in thousands) 106,033 106,457 116,976 117,153 117,353 117,540 117,540 117,540
Announcement Date 2/19/20 2/17/21 2/16/22 2/15/23 2/14/24 - - -
1USD
Estimates
2024 *2025 *
P/E ratio -8.35x 14x
PBR 1.23x 1.3x
EV / Sales 2.63x 2.67x
Yield 1.6% 1.64%
More valuation ratios * Estimated data

EPS & Dividend

eps-dividend-chart ALBEMARLE-CORPORATION

Year-on-year evolution of the PER

evolution-chart ALBEMARLE-CORPORATION

Year-on-year evolution of the Yield

evolution-chart ALBEMARLE-CORPORATION
Trading Rating
Investor Rating
ESG Refinitiv
C+
surperformance-ratings-light-chart ALBEMARLE-CORPORATIONMore Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
101.10USD
Average target price
116.41USD
Spread / Average Target
+15.14%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. ALB Stock
  4. Financials Albemarle Corporation